Related Experiment Video
Updated: Feb 11, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
PBX1 promotes the cell proliferation via JAK2/STAT3 signaling in clear cell renal carcinoma
1Department of Urology, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China.
Abstract:
PBX1 was abnormally overexpressed and its intracellular localization was found to be frequently amplified in many types of cancer, including renal clear cell carcinoma. PBX1 displays oncogenic activity in several different types of cells, but little is known about how signaling pathways are altered, and the function of PBX1 in renal clear cell carcinoma has not been well investigated. In this study, we demonstrate that the expression of PBX1 was significantly upregulated in 30 pairs of human tissues compared to adjacent normal tissues and the overall survival rate of PBX1-high group was significantly worse than that of PBX1-low group. Furthermore, JAK2 expression is significantly correlated to PBX1 expression in human clinical specimen and PBX1 knockdown inhibits STAT3 phosphorylation and reduced transcription of STAT3 target genes Cyclin D1. More interestingly, PBX1 knockdown inhibits ccRCC cell viability, proliferation and cell cycle progression in vivo and in vitro. Thus, our results demonstrate that PBX1 plays an oncogenic role in ccRCC via JAK2/STAT3 pathway and indicate its potential application for the treatment of human ccRCC in future.
Insights
PBX1 overexpression drives renal clear cell carcinoma (ccRCC) by activating the JAK2/STAT3 pathway. Inhibiting PBX1 shows promise for future ccRCC treatments.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- PBX1 is overexpressed in various cancers, including renal clear cell carcinoma (ccRCC), with its oncogenic role and pathway involvement poorly understood.
- Understanding PBX1's function in ccRCC is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of PBX1 in ccRCC pathogenesis.
- To explore the underlying signaling pathways, specifically the JAK2/STAT3 pathway, influenced by PBX1 in ccRCC.
Main Methods:
- Analyzed PBX1 expression in 30 human ccRCC tissue pairs versus adjacent normal tissues.
- Correlated PBX1 expression with patient survival rates.
- Investigated the effect of PBX1 knockdown on JAK2/STAT3 signaling, STAT3 target genes (Cyclin D1), and ccRCC cell behavior in vitro and in vivo.
Main Results:
- PBX1 expression was significantly upregulated in ccRCC tissues, correlating with poorer overall survival.
- PBX1 expression positively correlated with JAK2 expression.
- PBX1 knockdown suppressed STAT3 phosphorylation, reduced Cyclin D1 transcription, and inhibited ccRCC cell viability, proliferation, and cell cycle progression in vitro and in vivo.
Conclusions:
- PBX1 acts as an oncogene in ccRCC by activating the JAK2/STAT3 pathway.
- PBX1 is a potential therapeutic target for human ccRCC.
More Related Videos
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Related Concept Videos
What is Cell Signaling?
Cell-surface Signaling
Cells Coordinate Growth and Proliferation
Overview of Cell Signaling
Cells respond to many types of information, often through receptor proteins positioned on the membrane. For example, skin cells respond to and transmit touch...
Cell Signaling in Plants
Endocrine Signaling